ChAracterization of Normal and Pathological moRphological Variations of the TEMporomandibular Joint by Real-time magnetIc reSonance Imaging

NCT ID: NCT06070558

Last Updated: 2023-10-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-11-01

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Real Time MRI Rapid Flash sequence is particularly interesting for the study of moving organs and joints.

This sequence will make it possible to characterize normal and pathological temporomandibular joint movements by MRI.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Temporomandibular Joint Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy

Healthy volunteers

Group Type OTHER

MRI with Real Time MRI Rapid Flash sequence

Intervention Type DEVICE

MRI examination of temporomandibular joint with Real Time MRI Rapid Flash sequence

Temporomandibular Joint Disorders

Patients with Temporomandibular Joint Disorders

Group Type OTHER

MRI with Real Time MRI Rapid Flash sequence

Intervention Type DEVICE

MRI examination of temporomandibular joint with Real Time MRI Rapid Flash sequence

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MRI with Real Time MRI Rapid Flash sequence

MRI examination of temporomandibular joint with Real Time MRI Rapid Flash sequence

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult: age ≥ 18 years old;
* Person with the capacity to understand the instructions given;
* Person affiliated to a social security scheme or beneficiary of such a scheme;
* Person having received complete information on the organization of the Clinical Investigation and having signed informed consent.

Exclusion Criteria

* Person with large-scale metallic dental reconstructions;
* Edentulism more than 5 teeth;
* Claustrophobia;
* Contraindication to performing an MRI examination
* Persons referred to in Articles 64, 65 and 66 of European Regulation 2017/745 on Medical Devices (RDM) and in L. 1121-5 to L1121-8 of the French Public Health Code
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Central Hospital, Nancy, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pedro TEIXEIRA-GONDIM, MD

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHRU de Nancy

Nancy, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pedro Augusto GONDIM TEIXEIRA, MD, PhD

Role: CONTACT

0033 3 83 85 21 61

Gabriela Hossu, PhD

Role: CONTACT

0033 3 83 15 50 96

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A02648-33

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.